| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.085 | 0.2 |